Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
108.51
-0.34 (-0.31%)
Dec 5, 2025, 4:00 PM EST - Market closed
Glaukos Market Cap
Glaukos has a market cap or net worth of $6.23 billion as of December 5, 2025. Its market cap has decreased by -17.52% in one year.
Market Cap
6.23B
Enterprise Value
6.06B
1-Year Change
-17.52%
Ranking
Category
Stock Price
$108.51
Market Cap Chart
Since June 25, 2015, Glaukos's market cap has increased from $999.60M to $6.23B, an increase of 523.17%. That is a compound annual growth rate of 19.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 6.25B | -24.38% |
| Dec 31, 2024 | 8.27B | 113.12% |
| Dec 29, 2023 | 3.88B | 86.16% |
| Dec 30, 2022 | 2.08B | - |
| Dec 31, 2021 | 2.08B | -38.42% |
| Dec 31, 2020 | 3.38B | 68.22% |
| Dec 31, 2019 | 2.01B | -0.60% |
| Dec 31, 2018 | 2.02B | 128.25% |
| Dec 29, 2017 | 886.60M | -22.95% |
| Dec 30, 2016 | 1.15B | 45.18% |
| Dec 31, 2015 | 792.60M | -20.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |